Why MannKind Corporation (MNKD) is One of the Best Stocks Under $5 With Huge Upside Potential [Yahoo! Finance]
MannKind Corporation (MNKD)
Last mannkind corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.mannkindcorp.com/press-releases
Company Research
Source: Yahoo! Finance
Corporation (NASDAQ:MNKD) to $8 from $10 on April 13 and reaffirmed an Outperform rating on the shares. The firm adjusted price targets and estimates for a number of stocks under its coverage in the medical devices and diagnostics group ahead of its fiscal Q1 earnings. Is MannKind Corporation (MNKD) the Best Cancer Stock to Invest in for Long-Term Gain? MannKind Corporation (NASDAQ:MNKD) also received a rating update from Truist on April 8. The firm cut the price target on the stock to $6 from $7, reiterating a Buy rating on the shares. The rating update came as part of a broader research note previewing fiscal Q1 earnings in Biotech, with the firm telling investors in the research note that reactivity to regulatory and policy shifts across the sector is continuing to ease. Truist also stated that it is seeing a recent pickup in deal activity, which holds the potential to build momentum through the remainder of the year into midterms. The firm sees a robust catalyst path for Man
Show less
Read more
Impact Snapshot
Event Time:
MNKD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MNKD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MNKD alerts
High impacting MannKind Corporation news events
Weekly update
A roundup of the hottest topics
MNKD
News
- MannKind (MNKD) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Oryon Cell Therapies Appoints Burkhard Blank, M.D., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- MannKind (MNKD) was given a new $8.00 price target by Mizuho.MarketBeat
- Is MannKind Corporation (MNKD) One of the Popular Penny Stocks on Robinhood to Buy? [Yahoo! Finance]Yahoo! Finance
- How The MannKind (MNKD) Story Is Shifting As Tyvaso Risks Meet Afrezza And Furoscix Potential [Yahoo! Finance]Yahoo! Finance
MNKD
Earnings
- 2/26/26 - Beat
MNKD
Sec Filings
- 4/7/26 - Form ARS
- 4/7/26 - Form DEFA14A
- 4/7/26 - Form DEF
- MNKD's page on the SEC website